Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery

The requested reference [520d61a591c8417030388c016b8ab8e7bb80de88] no longer exists in our database. It has been replaced by the current reference: [73ea625f132c457ab3df5dcf6a178f01cadafd7c]

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
This is a double-blind randomized controlled trial evaluating the effect of perioperative dual bronchodilator therapy on post-operative pulmonary function and health-related quality of life (QoL) in mild-to-moderate less symptomatic COPD patients undergoing lung cancer surgery. Investigators hypothesized that dual bronchodilator, as compared with placebo, would prevent reduction of pulmonary function after surgical resection and improve postoperative health related QoL.
Epistemonikos ID: 1afd8f910494ce67f88a65f90340cf0c81106a9f
First added on: Dec 20, 2022